Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

GLICLAZIDE IMPURITY B CRS (50MG)

GLICLAZIDE IMPURITY B CRS (50MG)

NA

DISCOVER
GLICLAZIDE IMPURITY F CRS (70MG)

GLICLAZIDE IMPURITY F CRS (70MG)

NA

DISCOVER
GLIPIZIDE CRS (50 MG)

GLIPIZIDE CRS (50 MG)

29094-61-9

DISCOVER
GLIPIZIDE IMPURITY A CRS (15 MG)

GLIPIZIDE IMPURITY A CRS (15 MG)

NA

DISCOVER
GLUTAMIC ACID CRS (50 MG)

GLUTAMIC ACID CRS (50 MG)

56-86-0

DISCOVER
Gemcitabine HCl

Gemcitabine HCl

122111-03-9

DISCOVER
Glutethimide - * psy CRS, 50mg

Glutethimide - * psy CRS, 50mg

77-21-4

DISCOVER
Ganciclovir

Ganciclovir

82410-32-0

DISCOVER
Gentamicin Deuterated Pentaacetate Salt

Gentamicin Deuterated Pentaacetate Salt

NA

DISCOVER
GLYCEROL (85 PER CENT) - REFERENCE SPECTRUM (N/A)

GLYCEROL (85 PER CENT) - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
GLYCEROL MONOLINOLEATE CRS (2000 MG)

GLYCEROL MONOLINOLEATE CRS (2000 MG)

26545-74-4

DISCOVER
GLYCEROL MONO-OLEATE CRS (2500 MG)

GLYCEROL MONO-OLEATE CRS (2500 MG)

25496-72-4

DISCOVER